Related Experiment Video
Updated: Jun 16, 2026
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
Brain Stem Glioma Recurrence: Exploring the Therapeutic Frontiers
Francesco Pasqualetti1, Giuseppe Lombardi2, Giovanni Gadducci1
1Division of Radiation Oncology, Azienda Ospedaliero Universitaria Pisana, 56100 Pisa, Italy.
Abstract:
Gliomas of the brainstem represent a small percentage of central nervous system gliomas in adults. Due to the proximity of the tumor to critical structures, radical surgery is highly challenging and limited to selected cases. In addition, postoperative treatments, which become exclusive to non-operable patients, do not guarantee satisfactory disease control, making the progression of the disease inevitable. Currently, there is a lack of therapeutic options to control tumor growth after the diagnosis of recurrence. The rarity of these tumors, their distinct behavioral characteristics, and the limited availability of tumor tissue necessary for the development of prognostic and predictive biomarkers contribute to the absence of a standardized approach for treating recurrent brainstem gliomas. A salvage radiotherapy (RT) retreatment could represent a promising approach for recurrent brainstem gliomas. However, to date, it has been mainly evaluated in pediatric cases, with few experiences available to assess the most appropriate RT dose, safety, and clinical responses in adult patients. This comprehensive review aims to identify instances of adult patients with recurrent brainstem gliomas subjected to a secondary course of RT, with a specific focus on the analysis of treatment-related toxicity and outcomes. Through this investigation, we endeavor to contribute valuable insights into the viability and efficacy of salvage RT retreatment in managing recurrent brainstem gliomas in the adult population.
Insights
Salvage radiotherapy retreatment shows promise for recurrent brainstem gliomas in adults. This review analyzes toxicity and outcomes of secondary radiation in adult patients, offering insights for this challenging condition.
Area of Science:
- Neuro-oncology
- Radiation Oncology
Background:
- Brainstem gliomas are rare central nervous system tumors in adults.
- Surgical resection is often limited due to tumor location, and current treatments offer insufficient disease control for recurrent cases.
- There's a lack of effective therapeutic options for recurrent brainstem gliomas, necessitating novel treatment strategies.
Purpose of the Study:
- To review and analyze the safety and efficacy of salvage radiotherapy retreatment in adult patients with recurrent brainstem gliomas.
- To identify appropriate radiation therapy (RT) doses, treatment-related toxicity, and clinical outcomes in this specific patient population.
Main Methods:
- Comprehensive literature review of adult patients with recurrent brainstem gliomas who received a secondary course of radiotherapy.
- Analysis of treatment-related toxicity and patient outcomes.
Main Results:
- Salvage radiotherapy retreatment is a potential option for recurrent brainstem gliomas, though data in adults is limited.
- Further research is needed to establish optimal RT doses and protocols for adult patients.
Conclusions:
- Salvage radiotherapy retreatment may offer a viable therapeutic strategy for recurrent brainstem gliomas in adults.
- This review highlights the need for more data on toxicity and efficacy to guide clinical practice.
